je.st
news
Tag: merck
Merck to Hold Second-Quarter 2014 Sales and Earnings Conference Call on July 29
2014-06-23 23:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its second-quarter 2014 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Tuesday, July 29. During the call, company executives will provide an overview of Mercks performance for the quarter. Language: English Contact: MerckMedia:Lainie Keller, 908-423-4187Steven Cragle, 908-423-3461orInvestor:Justin Holko, 908-423-5088Joe Romanelli, 908-423-5185 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Merck Names Michael J. Holston as Future General Counsel; Will Succeed Bruce N. Kuhlik in July 2015
2014-06-23 14:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the future appointment of Michael J. Holston as general counsel, effective July 01, 2015. Holston, who will also oversee responsibility for Mercks communications, policy and security organizations beginning July 1 of this year, will succeed Bruce N. Kuhlik upon his retirement after ten years with the company. Holston will remain in his role as chief ethics and compliance officer during the transition period. Language: English Contact: Media:Pam Eisele, 267-305-3558orLainie Keller, 908-423-4187orInvestors:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: general
july
future
michael
Merck starting tender offer for Idenix
2014-06-20 17:00:20| Biotech - Topix.net
Merck is starting a tender offer on Friday to buy all of the outstanding shares of hepatitis C treatment maker Idenix Pharmaceuticals Inc. Merck & Co.
Tags: offer
starting
tender
merck
Merck Begins Tender Offer to Acquire Idenix
2014-06-20 13:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX). On June 09, 2014, Merck announced its intent to acquire Idenix. Language: English Contact: Media:Pamela Eisele, 267-305-3558Steve Cragle, 908-423-3461Investors:Joe Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: offer
begins
acquire
tender
Merck Animal Health Announces Appointment of Dr. Mark Engle to the Swine Technical Services Team
2014-06-19 16:05:00| National Hog Farmer
Source: Merck Animal Health Merck Animal Health today announced that Mark Engle, D.V.M, MS, has joined the company as a senior technical services manager for the Swine Business Unit. Dr. Engle received his doctor of veterinary medicine degree from Iowa State University and his master of science from the University of Minnesota. Dr. Engle has worked in private practice and swine farm management, as well as for swine genetics companies. He was most recently with the Pig Improvement Company. read more
Tags: services
health
team
mark
Sites : [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] next »